Clinical Trial Update: Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating irinotecan, carboplatin, and sunitinib as first-line treatment for extensive-stage small cell lung cancer has been completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• irinotecan, carboplatin, and sunitinib

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-02-15